| VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. |
2024-02-07 |
| Scion Life Sciences. (2/7/24). "Press Release: Scion Life Sciences Launches with Oversubscribed $310 Million Fund to Create and Build Exceptional Biotech Companies". New York, NY. |
2024-02-07 |
| MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. |
2024-02-05 |
| Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. |
2024-02-05 |
| ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. |
2024-02-01 |
| Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". |
2024-02-01 |
| Gilead Sciences, Inc.. (2/1/24). "Press Release: Ted Love, MD, Joins Gilead Sciences’ Board of Directors". Foster City, CA. |
2024-02-01 |
| Silence Therapeutics plc. (1/31/24). "Press Release: Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference". London. |
2024-01-31 |
| BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. |
2024-01-31 |
| ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. |
2024-01-30 |
| Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. |
2024-01-30 |
| Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
| BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. |
2024-01-30 |
| Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. |
2024-01-29 |
| SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". |
2024-01-26 |
| SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". |
2024-01-26 |
| Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. |
2024-01-25 |
| Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel. |
2024-01-25 |
| InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. |
2024-01-25 |
| BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
| Prism BioLab Co., Ldt.. (1/24/24). "Press Release: Prism BioLab Raises 1.5 Billion Yen in Series C Fundraising to Advance Technologies and Programs Targeting Protein-protein Interactions". Tokyo. |
2024-01-24 |
| IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
| Bristol Myers Squibb Company. (1/23/24). "Press Release: Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio". Princeton, NJ. |
2024-01-23 |
| Precisio Biotix Therapeutics, Inc.. (1/23/24). "Press Release: Precisio Biotix Therapeutics Expands the US Management Team WIth the Hiring of Dr. Raymond Schuch". Dover, DE. |
2024-01-23 |
| BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. |
2024-01-23 |
| Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. |
2024-01-23 |
| Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg. |
2024-01-22 |
| ReiThera S.r.l.. (1/22/24). "Press Release: ReiThera Srl, the Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation". Rome & Cambridge, MA. |
2024-01-22 |
| BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. |
2024-01-22 |
| Mirae Asset Capital Life Science. (1/18/24). "Press Release: Mirae Asset Capital Life Science Emerges from Stealth with $50M Fund". Boston, MA & San Francisco, CA. |
2024-01-18 |
| CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. |
2024-01-17 |
| Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. |
2024-01-16 |
| WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
| Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres. |
2024-01-10 |
| BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. |
2024-01-09 |
| Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". |
2024-01-09 |
| Catalym GmbH. (1/9/24). "Press Release: Catalym Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists". Mainz. |
2024-01-09 |
| GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". |
2024-01-09 |
| Johnson & Johnson. (1/8/24). "Press Release: Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer". New Brunswick, NJ. |
2024-01-08 |
| Aion Labs. (1/8/24). "Press Release: Aion Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation". Rehovot. |
2024-01-08 |
| Merck & Co., Inc.. (1/8/24). "Press Release: Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline". Rahway, NJ & South San Francisco, CA. |
2024-01-08 |
| Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. |
2024-01-08 |
| CellPhenomics GmbH. (1/8/24). "Press Release: CellPhenomics and Charles River Announce Agreement, Expanding 3D in vitro Services for Cancer Therapy Drug Screening". Berlin & Wilmington, MA. |
2024-01-08 |
| Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. |
2024-01-08 |
| Delfi Diagnostics, Inc.. (1/5/24). "Press Release: Delfi Diagnostics Appoints Susan Tousi as New Chief Executive Officer". Baltimore, MD & Palo Alto, CA. |
2024-01-05 |
| Immunic, Inc.. (1/5/24). "Press Release: Immunic, Inc. Announces Private Placement of up to $240 Million". New York, NY. |
2024-01-05 |
| CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. |
2024-01-05 |
| GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil. |
2024-01-05 |
| Twist Bioscience Corporation. (1/5/24). "Press Release: Twist Bioscience Appoints Adam Laponis as Chief Financial Officer". South San Francisco, CA. |
2024-01-05 |
| SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai. |
2024-01-05 |
| Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY. |
2024-01-04 |
| Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. |
2024-01-04 |
| Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. |
2024-01-04 |
| Moonwalk Biosciences. (1/4/24). "Press Release: Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines". South San Francisco, CA & San Diego, CA. |
2024-01-04 |
| Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. |
2024-01-04 |
| Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford. |
2024-01-04 |
| Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. |
2024-01-04 |
| Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. |
2024-01-04 |
| Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. |
2024-01-03 |
| Goldman Sachs Asset Management. (1/3/24). "Press Release: Goldman Sachs Asset Management Raises $650 Million for West Street Life Sciences I". New York, NY. |
2024-01-03 |
| Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim. |
2024-01-03 |
| CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. |
2024-01-03 |
| Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. |
2024-01-03 |
| Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing". Watertown, MA. |
2024-01-03 |
| Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Closes $60 Million Financing to Advance REM-422, Pipeline of Small Molecule Therapies Designed to Reprogram RNA Processing to Treat Disease". Cambridge, MA. |
2024-01-03 |
| MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. |
2024-01-02 |
| Tome Biosciences, Inc.. (1/2/24). "Press Release: Tome Biosciences Acquires Replace Therapeutics". Watertown, MA. |
2024-01-02 |
| Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA. |
2024-01-02 |
| ImmunityBio, Inc.. (1/2/24). "Press Release: ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million". Culver City, CA. |
2024-01-02 |
| Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. |
2024-01-02 |
| Chimerix, Inc.. (12/29/23). "Press Release: Chimerix Appoints Lisa Decker to Board of Directors". Durham, NC. |
2023-12-29 |
| Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel. |
2023-12-29 |
| Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. |
2023-12-27 |
| PAI Partners SAS. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". |
2023-12-27 |
| Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA. |
2023-12-26 |
| AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". |
2023-12-26 |
| Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners]
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest eve |
2023-12-26 |
| Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. |
2023-12-26 |
| Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA. |
2023-12-22 |
| GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris. |
2023-12-22 |
| Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference". Princeton, N.J.. |
2023-12-22 |
| Remix Therapeutics, Inc.. (12/21/23). "Press Release: Remix Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference". Watertown, MA. |
2023-12-21 |
| ITM Isotope Technologies Munich SE. (12/21/23). "Press Release: ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Garching. |
2023-12-21 |
| Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna. |
2023-12-21 |
| UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". |
2023-12-21 |
| Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA. |
2023-12-20 |
| Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. |
2023-12-20 |
| Ionis Pharmaceuticals, Inc.. (12/20/23). "Press Release: Ionis to Present at 42nd Annual J.P. Morgan Healthcare Conference". Carlsbad, CA. |
2023-12-20 |
| GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London. |
2023-12-20 |
| Bristol Myers Squibb Company. (12/20/23). "Press Release: Bristol Myers Squibb to Participate in the 2024 Goldman Sachs Healthcare C-Suite Unscripted Conference". Princeton, N.J.. |
2023-12-20 |
| CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. |
2023-12-19 |
| LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
| Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer". |
2023-12-19 |
| Ionis Pharmaceuticals, Inc.. (12/18/23). "Press Release: Ionis Announces European Licensing Agreement with Otsuka for Donidalorsen in Hereditary Angioedema". Carlsbad, CA. |
2023-12-18 |
| Agilent Technologies Inc.. (12/18/23). "Press Release: Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Santa Clara, CA. |
2023-12-18 |
| Twist Bioscience Corporation. (12/18/23). "Press Release: Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference". South San Francisco, CA. |
2023-12-18 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne. |
2023-12-15 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne. |
2023-12-15 |
| EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies". |
2023-12-14 |
| AstraZeneca plc. (12/12/23). "Press Release: AstraZeneca to Acquire Icosavax, Including Potential First-in-Class RSV and hMPV Combination Vaccine with Positive Phase II Data". |
2023-12-12 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
1 2 3 ... 76 77 78 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
